文献速递心力衰竭与心肌病瓣膜病与结构性心脏病

儿童及青少年肥厚型心肌病晚期钆增强的患病率与进展

Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
PubMed 文献 · Circulation · 2018-01-01

该回顾性观察研究分析了195例≤21岁患者的心脏磁共振,其中155例为明确肥厚型心肌病(HCM),40例为无左心室肥厚的肌节突变携带者。明确HCM患者中晚期钆增强(LGE)患病率为46%,中位范围3.3%;

要点

  • 儿童及青少年明确HCM的LGE患病率为46%,低于成人常见的约60%。
  • 无左心室肥厚的肌节突变携带者中未检出LGE。
  • 系列影像显示LGE范围、左心室质量和左心房容积指数随时间显著增加。

核心结论

  • 儿童及青少年明确HCM中LGE患病率为46%,低于成人报告的约60%。
  • 在系列影像亚组中,LGE范围、左心室质量和左心房大小在约2.5年内显著增加,提示疾病进展。

研究设计与样本

  • 观察性回顾性研究,分析195例≤21岁患者的心脏磁共振,包括155例明确HCM和40例无左心室肥厚的肌节突变携带者。
  • LGE范围通过测量信号强度高于远端心肌6个标准差以上的区域进行量化。

主要发现

  • 明确HCM患者中70例(46%)存在LGE,中位范围3.3%(四分位距0.8-7.1%);无左心室肥厚的突变携带者中LGE缺失。
  • LGE中位范围从占左心室质量的2.9%(四分位距0.8-3.2%)增至4.3%(四分位距2.9-6.8%),中位增加2.4 g/年(范围0-13.2 g/年),P=0.02。
  • 除LGE外,左心室质量、左心房容积指数(均经体表面积索引)及左心室质量z评分从首次至最近一次心脏磁共振显著增加。

临床怎么用

  • 对儿童及青少年HCM患者,应考虑使用心脏磁共振监测LGE及心脏结构变化以评估疾病进展。
  • 无左心室肥厚的肌节突变携带者中LGE缺失,提示LGE可能反映明确心肌病变后的纤维化。

局限性

  • 为回顾性观察研究,需进一步前瞻性研究确认 findings 及LGE在儿童HCM中的临床意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Late gadolinium enhancement (LGE) on cardiac magnetic resonance imaging (CMR) is believed to represent dense replacement fibrosis. It is seen in ≈60% of adult patients with hypertrophic cardiomyopathy (HCM). However, the prevalence of LGE in children and adolescents with HCM is not well established. In addition, longitudinal studies describing the development and evolution of LGE in pediatric HCM are lacking. This study assesses the prevalence, progression, and clinical correlations of LGE in children and adolescents with, or genetically predisposed to, HCM. METHODS: CMR scans from 195 patients ≤21 years of age were analyzed in an observational, retrospective study, including 155 patients with overt HCM and 40 sarcomere mutation carriers without left ventricular (LV) hypertrophy. The extent of LGE was quantified by measuring regions with signal intensity >6 SD above nulled remote myocardium. RESULTS: Patients were 14.3±4.5 years of age at baseline and 68% were male. LGE was present in 70 (46%) patients with overt HCM (median extent, 3.3%; interquartile range, 0.8-7.1%), but absent in mutation carriers without LV hypertrophy. Thirty-one patients had >1 CMR (median interval between studies, 2.4 years; interquartile range, 1.5-3.2 years). LGE was detected in 13 patients (42%) at baseline and in 16 patients (52%) at follow-up CMR. The median extent of LGE increased by 2.4 g/y (range, 0-13.2 g/y) from 2.9% (interquartile range, 0.8-3.2%) of LV mass to 4.3% (interquartile range, 2.9-6.8%) ( P=0.02). In addition to LGE, LV mass and left atrial volume, indexed to body surface area, and z score for LV mass, as well, increased significantly from first to most recent CMR. CONCLUSIONS: LGE was present in 46% of children and adolescents with overt HCM, in contrast to ≈60% typically reported in adult HCM. In the subset of patients with serial imaging, statistically significant increases in LGE, LV mass, and left atrial size were detected over 2.5 years, indicating disease progression over time. Further prospective studies are required to confirm these findings and to better understand the clinical implications of LGE in pediatric HCM.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Axelsson Raja A, Farhad H, Valente AM, et al. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy. Circulation. 2018. PMID: 29622585. doi:10.1161/CIRCULATIONAHA.117.032966

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。